Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more
Phytohealth Corp - Asset Resilience Ratio
Phytohealth Corp (4108) has an Asset Resilience Ratio of 44.51% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Phytohealth Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Phytohealth Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$1.04 Billion | 44.51% |
| Total Liquid Assets | NT$1.04 Billion | 44.51% |
Asset Resilience Insights
- Very High Liquidity: Phytohealth Corp maintains exceptional liquid asset reserves at 44.51% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Phytohealth Corp Industry Peers by Asset Resilience Ratio
Compare Phytohealth Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Phytohealth Corp (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Phytohealth Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 43.35% | NT$1.06 Billion | NT$2.44 Billion | -7.85pp |
| 2023-12-31 | 51.19% | NT$1.20 Billion | NT$2.35 Billion | -2.10pp |
| 2022-12-31 | 53.30% | NT$1.26 Billion | NT$2.36 Billion | -0.17pp |
| 2021-12-31 | 53.47% | NT$1.32 Billion | NT$2.47 Billion | +14.86pp |
| 2020-12-31 | 38.61% | NT$698.66 Million | NT$1.81 Billion | +4.35pp |
| 2019-12-31 | 34.25% | NT$644.66 Million | NT$1.88 Billion | +33.38pp |
| 2018-12-31 | 0.87% | NT$18.02 Million | NT$2.07 Billion | -47.48pp |
| 2017-12-31 | 48.35% | NT$1.06 Billion | NT$2.19 Billion | +4.22pp |
| 2016-12-31 | 44.13% | NT$1.07 Billion | NT$2.42 Billion | +26.22pp |
| 2015-12-31 | 17.91% | NT$419.00 Million | NT$2.34 Billion | -30.75pp |
| 2014-12-31 | 48.65% | NT$1.21 Billion | NT$2.49 Billion | -1.00pp |
| 2013-12-31 | 49.65% | NT$1.40 Billion | NT$2.82 Billion | +47.31pp |
| 2012-12-31 | 2.35% | NT$67.69 Million | NT$2.88 Billion | -11.98pp |
| 2011-12-31 | 14.33% | NT$236.51 Million | NT$1.65 Billion | -18.82pp |
| 2010-12-31 | 33.15% | NT$632.06 Million | NT$1.91 Billion | -11.99pp |
| 2009-12-31 | 45.14% | NT$954.21 Million | NT$2.11 Billion | +27.80pp |
| 2008-12-31 | 17.34% | NT$186.78 Million | NT$1.08 Billion | -13.55pp |
| 2007-12-31 | 30.89% | NT$480.49 Million | NT$1.56 Billion | +4.53pp |
| 2004-12-31 | 26.36% | NT$80.45 Million | NT$305.18 Million | -25.81pp |
| 2003-12-31 | 52.17% | NT$179.52 Million | NT$344.09 Million | +48.13pp |
| 2002-12-31 | 4.04% | NT$6.30 Million | NT$156.02 Million | -- |